Logotype for Momentum Group

Momentum Group (MMGR) Q4 2025 (Q&A) earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Momentum Group

Q4 2025 (Q&A) earnings summary

4 Aug, 2026

Executive summary

  • Revenue and earnings increased in 2025 despite a subdued and uncertain market, with gradual improvement in market signals across customer segments and regions.

  • Margin decline in Q4 for the industry segment was mainly due to lower volumes in the Specialist area and reduced contribution from acquisitions.

  • Organic growth improved slightly from Q3, with acquisitions contributing significantly to overall revenue growth.

  • Power transmission, the largest business, remained stable in margins despite slight volume decreases and high price pressure.

  • Six companies were acquired during the year, adding approximately SEK 300 million in annual revenue.

Financial highlights

  • Full-year 2025 revenue grew 8% to SEK 3,097 million (2,873), EBITA up 5% to SEK 337 million (322), and net profit up 5% to SEK 196 million (186).

  • Q4 revenue increased by 6% to SEK 792 million (745), with EBITA for Q4 rising 6% to SEK 74 million (70), and operating profit up 11% to SEK 59 million (53).

  • Earnings per share for the year were SEK 3.80 (3.60), up 6%.

  • EBITA margin for the year was 10.9% (11.2%).

  • Strong cash flow from operations: SEK 347 million (323).

Outlook and guidance

  • Market activity is stabilizing, with increased order inquiries and interest in system and project-related business, especially in defense, energy, and steel segments in Sweden and Finland.

  • Gradual market improvement expected, with positive signals in several sectors and geographies.

  • Target to double EBITA to around SEK 680 million by 2030, focusing on organic improvements, organizational development, and geographic expansion.

  • Board proposes a dividend of SEK 1.40 per share, an 8% increase, corresponding to a 37% payout ratio.

  • Danish market growth is expected to align with other Nordic markets as pharma demand normalizes.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more